A Comparative Study of Deep Learning Approaches for Amyotrophic Lateral Sclerosis Super-Resolution Image Classification

Authors

  • Hui Miao
  • Mathew Horrocks
  • Marta Vallejo

DOI:

https://doi.org/10.61173/nc7fkr37

Keywords:

TDP-43, DNA/RNA, Amyotrophic, Deep Learning Approaches, ALS patients

Abstract

Amyotrophic lateral sclerosis is a fatal degenerative neurological disease known as motor neuron disease. According to research, amyotrophic lateral sclerosis affects nerve cells related to movement in the brain and spinal cord, leading to the death of motor neurons, making the brain unable to control muscle movement, and resulting in a significant loss of motor nerve cells, leading to muscle atrophy. In the early stages of ALS, symptoms are mild, often go unnoticed, and can easily be confused with other diseases. Patients may only feel symptoms such as weakness, convulsions, and fatigue, gradually develop muscle atrophy all over the body, difficulty swallowing, and finally die of respiratory failure. TDP-43 is a DNA/RNA binding protein typically located in the nucleus regulating various steps of RNA metabolism. Meanwhile, TDP-43 is the most prominent pathological protein in the characteristics of ALS patients.[1] TDP-43 is depleted in the nucleus in nearly all ALS cases but accumulates in the cytoplasm.
Deep learning is learning the internal laws and representation levels of sample data. The information obtained from these learning processes can significantly help interpret data such as text, images, and sounds. Its goal is to enable machines to analyze and learn like humans and recognize data. Additionally, super-resolution microscopy can be used to observe the conformation of proteins in biological samples, thereby gaining insight into the structure and assembly mechanism of TDP-43 aggregates.
This project aims to use super-resolution images for machine learning to build a model for classifying ALS patients from non-ALS patients. At the same time, multiple neural network models are used for training and then compared to select the model with the highest accuracy.

Author Biographies

Mathew Horrocks

Edinburgh University

Marta Vallejo

Heriot-Watt University

References

[1] Journal articles: Mackenzie IR, Rademakers R. “The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia”. Curr Opin Neurol. 2008 Dec;21(6):693-700. doi: 10.1097/ WCO.0b013e3283168d1d. PMID: 18989115; PMCID: PMC2869081.

[2] Journal articles: Kim G, Gautier O, Tassoni-Tsuchida E, Ma XR, Gitler AD. “ALS Genetics: Gains, Losses, and Implications for Future Therapies”. Neuron. 2020 Dec 9;108(5):822-842. doi: 10.1016/j.neuron.2020.08.022. Epub 2020 Sep 14. PMID: 32931756; PMCID: PMC7736125.

[3] Journal articles: Yanpallewar S, Fulgenzi G, Tomassoni- Ardori F, Barrick C, Tessarollo L. “Delayed onset of inherited ALS by deletion of the BDNF receptor TrkB.T1 is non-cell autonomous.” Exp Neurol. 2021 Mar; 337:113576. doi: 10.1016/ j.expneurol.2020.113576. Epub 2020 Dec 24. PMID: 33359475; PMCID: PMC9229840.

[4] Journal articles: Marshall TM, Dardia GP, Colvin KL, Nevin R, Macrellis J. “Neurotoxicity Associated with Traumatic Brain Injury, Blast, Chemical, Heavy Metal and Quinoline Drug Exposure”. Altern Ther Health Med. 2019 Jan;25(1):28-34. PMID: 30982784.

[5] Journal articles: Dugan LL, Choi DW. “Excitotoxicity, free radicals, and cell membrane changes”. Ann Neurol. 1994;35 Suppl:S17-21. doi: 10.1002/ana.410350707. PMID: 8185290.

[6] Journal articles: Do Carmo S, Kannel B, Cuello AC. “The Nerve Growth Factor Metabolic Pathway Dysregulation as Cause of Alzheimer’s Cholinergic Atrophy”. Cells. 2021 Dec 22;11(1):16. doi: 10.3390/cells11010016. PMID: 35011577; PMCID: PMC8750266.

[7] Journal articles: van den Bos MAJ, Geevasinga N, Higashihara M, Menon P, Vucic S. “Pathophysiology and Diagnosis of ALS: Insights from Advances in Neurophysiological Techniques”. Int J Mol Sci. 2019 Jun 10;20(11):2818. doi: 10.3390/ijms20112818. PMID: 31185581; PMCID: PMC6600525.

[8] Journal articles: Liscic RM, Grinberg LT, Zidar J, Gitcho MA, Cairns NJ. “ALS and FTLD: two faces of TDP-43 proteinopathy”. Eur J Neurol. 2008 Aug;15(8):772-80. doi: 10.1111/j.1468-1331.2008.02195.x. PMID: 18684309; PMCID: PMC2801606.

[9] Journal articles: Scotter EL, Chen HJ, Shaw CE. “TDP- 43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets”. Neurotherapeutics. 2015 Apr;12(2):352-63. doi: 10.1007/s13311-015-0338-x. Erratum in: Neurotherapeutics. 2015 Apr;12(2):515-8. PMID: 25652699; PMCID: PMC4404432.

[10] Journal articles: Liu S, Hoess P, Ries J. “Super- Resolution Microscopy for Structural Cell Biology”. Annu Rev Biophys. 2022 May 9;51:301-326. doi: 10.1146/annurevbiophys-102521-112912. Epub 2022 Feb 4. PMID: 35119945.

[11] Journal articles: Miotto R, Wang F, Wang S, Jiang X, Dudley JT. “Deep learning for healthcare: review, opportunities and challenges”. Brief Bioinform. 2018 Nov 27;19(6):1236- 1246. doi: 10.1093/bib/bbx044. PMID: 28481991; PMCID: PMC6455466.

[12] Journal articles: Chen X, Wang X, Zhang K, Fung KM, Thai TC, Moore K, Mannel RS, Liu H, Zheng B, Qiu Y. “Recent advances and clinical applications of deep learning in medical image analysis”. Med Image Anal. 2022 Jul;79:102444. doi: 10.1016/j.media.2022.102444. Epub 2022 Apr 4. PMID: 35472844; PMCID: PMC9156578.

[13] Journal articles: Li Z, Liu F, Yang W, Peng S, Zhou J. “A Survey of Convolutional Neural Networks: Analysis, Applications, and Prospects”. IEEE Trans Neural Netw Learn Syst. 2022 Dec;33(12):6999-7019. doi: 10.1109/ TNNLS.2021.3084827. Epub 2022 Nov 30. PMID: 34111009. Dean&Francis

[14] Journal articles: Wang C, Duan Y, Duan G, Wang Q, Zhang K, Deng X, Qian B, Gu J, Ma Z, Zhang S, Guo L, Liu C, Fang Y. “Stress Induces Dynamic, Cytotoxicity-Antagonizing TDP-43 Nuclear Bodies via Paraspeckle LncRNA NEAT1- Mediated Liquid-Liquid Phase Separation”. Mol Cell. 2020 Aug 6;79(3):443-458.e7. doi: 10.1016/j.molcel.2020.06.019. Epub 2020 Jul 9. PMID: 32649883.

[15] Journal articles: Ederle H, Funk C, Abou-Ajram C, Hutten S, Funk EBE, Kehlenbach RH, Bailer SM, Dormann D. “Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/ CRM1”. Sci Rep. 2018 May 4;8(1):7084. doi: 10.1038/s41598- 018-25007-5. PMID: 29728564; PMCID: PMC5935713.

[16] Journal articles: Crook A, Jacobs C, Newton-John T, McEwen A. “Toward genetic counseling practice standards for diagnostic testing in amyotrophic lateral sclerosis and frontotemporal dementia”. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Nov;23(7-8):562-574. doi: 10.1080/21678421.2022.2051553. Epub 2022 Mar 27. PMID: 35343344.

[17] Journal articles: Saxon JA, Thompson JC, Harris JM, Ealing J, Hamdalla H, Chaouch A, Young C, Blackburn D, Majeed T, Gall C, Richardson AMT, Langheinrich T, Jones M, Snowden JS. “The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia”. Amyotroph Lateral Scler Frontotemporal Degener. 2020 Nov;21(7-8):606-613. doi: 10.1080/21678421.2020.1797090. Epub 2020 Aug 19. PMID: 32811199.

[18] Journal articles: Skandarani Y, Lalande A, Afilalo J, Jodoin PM. “Generative Adversarial Networks in Cardiology”. Can J Cardiol. 2022 Feb;38(2):196-203. doi: 10.1016/ j.cjca.2021.11.003. Epub 2021 Nov 13. PMID: 34780990.

[19] Journal articles: Frye S, Butterfield R, Hoffman JM. “SNMMI Clinical Trials Network Research Series for Technologists: Ethical Issues and Regulations in the Medical Workplace”. J Nucl Med Technol. 2021 Dec;49(4):303-310. doi: 10.2967/jnmt.121.263100. PMID: 34862262.

Downloads

Published

2023-10-22